8:00 am – 8:30 am Welcome – Introductions – Opening Remarks
8:30 am – 9:30 am Specialty Pharmacy – Still An Issue
Specialty pharmacy continues to challenge IDNs in the complexity of distribution, administration and patient management of already hyperinflated drugs. With pharmacy benefit management firms able in some cases to negotiate better prices and frequently offer a complete menu of specialty pharmaceuticals to health plans and employers, the question becomes one of strategy for health systems – do they build their own specialty pharmacy or partner with a commercial vendor?
- Analyze how the decision to build or partner plays out in inpatient care vs. outpatient/ambulatory.
- Outline the financial impact these strategies have.
- Specify what influence major payers have on the decisions health systems make?
9:30 am -- 9:45 am Break
9:45 am – 10:45 am Demand Planning/Forecasting
No more five-year plans! As IDNs grow in size and complexity, and the demands of payers and patients shift, planning for the next year becomes hard enough! Pharmacy is also reaching beyond hospital walls into the community through physician offices, satellite clinics, stand-alone ERs and so on. Planning for how to supply drugs for such a network hinges on a provider’s willingness to invest in some form of data analytics, and, just as importantly, act on those findings. A widespread absence of information technology systems that support and track interventions adds to the challenges care providers face.
- Demonstrate how to use forecasted demand to lower inpatient utilization.
- Formulate methods of using in-house analytics at similar cost and quality to that provided by third-party vendors.
- Compare and contrast the key performance indicators that really matter.
10:45 am – 11:00 am Break
11:00 am – 12:00 pm Benchmarking
Providers need information tools to help benchmark pharmacy performance by hospital and medical group and against nationwide averages. Many vendors provide such tools, which include dashboards that track a range of metrics such as drug expenditures per adjusted inpatient day and antibiotic utilization by drug and clinical application. Systems also provide clinical decision support materials to validate purchasing changes and discussions in pharmacy and therapeutics meetings.
- Evaluate methods of promulgating benchmarked pharmacy data throughout the health system to get people’s attention.
- Analyze how benchmarks help reduce the number of drugs per category to lower our drug spend.
- Identify key performance indicators we should be focused on that we are not today.
All information is subject to change. Last updated 06/06/17.